Immutep
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immutep and other ETFs, options, and stocks.About IMMP
Immutep Ltd. is a clinical stage biotechnology company, which engages in the development of LAG-3 related immunotherapeutic products for cancer and autoimmune diseases. Its products include eftilagimod alfa (IMP321), IMP761, leramilimab (IMP701), and GSK‘781 (IMP731).
CEOMarc Voigt
CEOMarc Voigt
Employees—
Employees—
HeadquartersSydney, New South Wales (NSW)
HeadquartersSydney, New South Wales (NSW)
Founded1987
Founded1987
Employees—
Employees—
IMMP Key Statistics
Market cap46.13M
Market cap46.13M
Price-Earnings ratio-0.85
Price-Earnings ratio-0.85
Dividend yield—
Dividend yield—
Average volume593.77K
Average volume593.77K
High today$0.329
High today$0.329
Low today$0.3025
Low today$0.3025
Open price$0.3215
Open price$0.3215
Volume895.21K
Volume895.21K
52 Week high$3.53
52 Week high$3.53
52 Week low$0.3025
52 Week low$0.3025
IMMP News
TipRanks 3d
Immutep Ends Key Lung Cancer Trial but Stresses Strength of PipelineUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
Analyst ratings
67%
of 6 ratingsBuy
33.3%
Hold
66.7%
Sell
0%
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.